Fexofenadine Hydrochloride Tablet
Product Images NDC 71309-091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride (NDC 71309-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safrel Pharmaceuticals, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fexo (Screen Shot 2022 01 21 At 12.42.58 Am Copy)

Fexo (Screen Shot 2022 01 21 At 12.42.58 Am Copy)
Drug Facts panel for Safrel Allergy Relief tablets with 180 mg Fexofenadine Hydrochloride, an antihistamine. The panel includes active ingredient, uses for indoor/outdoor allergy symptoms, warnings, directions for use by age group and health conditions, storage information, inactive ingredients, and a contact number for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.